376
Participants
Start Date
October 31, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Hydrochloride Carliprazine capsules
Oral administration, once daily, with a total treatment duration of 6 weeks after successful screening.
Aripiprazole tablets
Oral administration, once daily, with a total treatment duration of 6 weeks after successful screening.
Lead Sponsor
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
INDUSTRY